Bacterial meningitis from Rothia mucilaginosa in patients with malignancy or undergoing hematopoietic stem cell transplantation

Pediatric Blood and Cancer

Volumn 50, Issue 3, 2008, Pages 673-676

  Lee Md, Alisa B ^a   Harker Murray, Paul ^b   Ferrieri, Patricia ^b   Schleiss, Mark R ^b   Tolar, Jakub ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

Author keywords

Bone marrow; Intrathecal; Intraventricular; Micrococcus; Oncology

Indexed keywords

AMIKACIN; AMPICILLIN; AZTREONAM; CEFOTAXIME; CEFTAZIDIME; CHLORAMPHENICOL; CLARITHROMYCIN; COTRIMOXAZOLE; FLUCLOXACILLIN; FOSFOMYCIN; GENTAMICIN; IMIPENEM; MEROPENEM; NAFCILLIN; OXACILLIN; PENICILLIN G; RIFAMPICIN; THIAMPHENICOL; TIMENTIN; TOBRAMYCIN; VANCOMYCIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL MENINGITIS; BACTERIAL STRAIN; CANCER PATIENT; CASE REPORT; DISEASE SEVERITY; DRUG SUBSTITUTION; FATALITY; FEMALE; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; MALE; MORBIDITY; MORTALITY; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; RARE DISEASE; ROTHIA MUCILAGINOSA; SCHOOL CHILD;

ACTINOMYCETALES INFECTIONS; ADOLESCENT; ANTI-BACTERIAL AGENTS; CEFTAZIDIME; CEREBROSPINAL FLUID SHUNTS; CHILD; CORD BLOOD STEM CELL TRANSPLANTATION; DRUG THERAPY, COMBINATION; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; LEUKEMIA, MEGAKARYOBLASTIC, ACUTE; MALE; MENINGITIS, BACTERIAL; MICROCOCCACEAE; OPPORTUNISTIC INFECTIONS; POSTOPERATIVE COMPLICATIONS; RIFAMPIN; SEPSIS; THIENAMYCINS; VANCOMYCIN;

EID: 38549105995     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21286     Document Type: Article

References (22)

1. Zinner SH. Changing epidemiology of infections in patients with neutropenia and cancer: Emphasis on gram-positive and resistant bacteria. Clin Infect Dis 1999;29:490-494.
2. Bergan T, Bovre K, Hovig B. Reisolation of Micrococcus mucilaginosus Migula 1900. Acta Pathol Microbiol Scand [B] Microbiol Immunol 1970;78:85-97.
3. Gordon DF, Jr. Reisolation of Staphylococcus salivarius from the human oral cavity. J Bacteriol 1967;94:1281-1286.
4. Bergan T, Kocur M. Stomatococcus mucilaginosus gen. nov., sp. nov., ep. rev., a member of the family Micrococcaceae. Int J Syst Bacteriol 1982;32:374-377.
5. McWhinney PH, Kibbler CC, Gillespie SH, et al. Stomatococcus mucilaginosus: An emerging pathogen in neutropenic patients. Clin Infect Dis 1992;14:641-646.
6. van Tiel FH, Slangen BF, Schouten HC, et al. Study of Stomatococcus mucilaginosus isolated in a hospital ward using phenotypic characterization. Eur J Clin Microbiol Infect Dis 1995;14:193-198.
7. von Eiff C, Herrmann M, Peters G. Antimicrobial susceptibilities of Stomatococcus mucilaginosus and of Micrococcus spp. Antimicrob Agents Chemother 1995;39:268-270.
8. Schaad UB, Nelson JD, McCracken GH Jr. Pharmacology and efficacy of vancomycin for staphylococcal infections in children. Rev Infect Dis 1981;3:S282-288.
9. Luer MS, Hatton J. Vancomycin administration into the cerebrospinal fluid: A review. Ann Pharmacother 1993;27:912-921.
10. Skogen PG, Kolmannskog S, Bergh K. Bactericidal activity in cerebrospinal fluid by treating meningitis caused by Stomatococcus mucilaginosus with rifampicin, cefotaxime and vancomycin in a neutropenic child. Clin Microbiol Infect 2001;7:39-42.
11. Kaiser AB, McGee ZA. Aminoglycoside therapy of gram-negative bacillary meningitis. N Engl J Med 1975;293:1215-1220.
12. Al-Fiar F, Ellis M, Qadri SMH, et al. Stomatococcus mucilaginosus meningitis in a patient with acute lymphoblastic leukemia. Ann Saudi Med 1995;15:94121.
13. Clausen CR. Central nervous system infection due to Stomatococcus mucilaginosus. Clin Microbiol Newsl 1992;14:87-88.
14. Goldman M, Chaudhary UB, Greist A, et al. Central nervous system infections due to Stomatococcus mucilaginosus in immunocompromised hosts. Clin Infect Dis 1998;27:1241-1246.
15. Park MK, Khan J, Stock F, et al. Successful treatment of Stomatococcus mucilaginosus meningitis with intravenous vancomycin and intravenous ceftriaxone. Clin Infect Dis 1997;24:278.
16. Souillet G, Chomarat M, Barbe G, et al. Stomatococcus mucilaginosus meningitis in a child with leukemia. Clin Infect Dis 1992;15:1045.
17. Guermazi A, Miaux Y, Laval-Jeantet M. Imaging of choroid plexus infection by Stomatococcus mucilaginosus in neutropenic patients. AJNR Am J Neuroradiol 1995;16:1331-1334.
18. Henwick S, Koehler M, Patrick CC. Complications of bacteremia due to Stomatococcus mucilaginosus in neutropenic children. Clin Infect Dis 1993;17:667-671.
19. Weinblatt ME, Sahdev I, Berman M. Stomatococcus mucilaginosus infections in children with leukemia. Pediatr Infect Dis J 1990;9:678-679.
20. Abraham J, Bilgrami S, Dorsky D, et al. Stomatococcus mucilaginosus meningitis in a patient with multiple myeloma following autologous stem cell transplantation. Bone Marrow Transplant 1997;19:639-641.
21. Ben Salah H, Crockaert F, Levy J, et al. Stomatococcus mucilaginosus meningitis in immunocompromised child. Arch Pediatr 1994;1:813-815.
22. Chanock SJ, Toltzis P, Wilson C. Cross-reactivity between Stomatococcus mucilaginosus and latex agglutination for cryptococcal antigen. Lancet 1993;342:1119-1120.